Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Osteoporosis"" wg kryterium: Temat


Starter badań:

Tytuł:
Baseline serum PINP level is associated with the increase in hip bone mineral density seen with Romosozumab treatment in previously untreated women with osteoporosis.
Autorzy:
Kashii M; Department of Orthopedic Surgery, Toyonaka Municipal Hospital, 4-14-1 Shibaharacho, Toyonaka, Osaka, 560-8565, Japan.
Kamatani T; Department of Orthopedic Surgery, Toyonaka Municipal Hospital, 4-14-1 Shibaharacho, Toyonaka, Osaka, 560-8565, Japan.
Nagayama Y; Nagayama Rheumatology and Orthopaedic Clinic, 4-3-25 Hiokisounishimachi, Higashi-Ku, Sakai, 599-8114, Japan.
Miyama A; Department of Orthopaedic Surgery, Osaka Toneyama Medical Center, 5-1-1 Toneyama, Toyonaka, Osaka, 560-8552, Japan.
Tsuboi H; Department of Orthopaedic Surgery, Osaka Rosai Hospital, 1179-3 Nagasonecho, Kita-Ku, Sakai, 591-8025, Japan.
Ebina K; Department of Musculoskeletal Regenerative Medicine, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan. .; Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine, 2-2 Yamada-Oka, Suita, Osaka, 565-0871, Japan. .
Pokaż więcej
Źródło:
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA [Osteoporos Int] 2023 Mar; Vol. 34 (3), pp. 563-572. Date of Electronic Publication: 2022 Dec 31.
Typ publikacji:
Observational Study; Multicenter Study; Journal Article
MeSH Terms:
Bone Density*/drug effects
Bone Density Conservation Agents*/pharmacology
Bone Density Conservation Agents*/therapeutic use
Osteoporosis, Postmenopausal*/blood
Osteoporosis, Postmenopausal*/diagnostic imaging
Osteoporosis, Postmenopausal*/drug therapy
Aged ; Female ; Humans ; Biomarkers/blood ; Lumbar Vertebrae/diagnostic imaging ; Lumbar Vertebrae/drug effects ; Osteoporosis ; Procollagen/blood ; Prospective Studies ; Teriparatide ; Femur Neck/diagnostic imaging ; Femur Neck/drug effects ; Pelvic Bones/diagnostic imaging ; Pelvic Bones/drug effects
Czasopismo naukowe
Tytuł:
No genetic causal association between iron status and osteoporosis: A two-sample Mendelian randomization.
Autorzy:
Xu J; Orthopedic Research Institute, Department of Orthopedics, Sichuan University West China Hospital, Chengdu, Sichuan, China.
Ma J; Orthopedic Research Institute, Department of Orthopedics, Sichuan University West China Hospital, Chengdu, Sichuan, China.
Chen J; Orthopedic Research Institute, Department of Orthopedics, Sichuan University West China Hospital, Chengdu, Sichuan, China.
Zhang S; Orthopedic Research Institute, Department of Orthopedics, Sichuan University West China Hospital, Chengdu, Sichuan, China.; Department of Orthopedics, The Third Hospital of Mianyang, Sichuan Mental Health Center, Mianyang, Sichuan, China.
Zheng C; Orthopedic Research Institute, Department of Orthopedics, Sichuan University West China Hospital, Chengdu, Sichuan, China.
Si H; Orthopedic Research Institute, Department of Orthopedics, Sichuan University West China Hospital, Chengdu, Sichuan, China.
Wu Y; Orthopedic Research Institute, Department of Orthopedics, Sichuan University West China Hospital, Chengdu, Sichuan, China.
Liu Y; Orthopedic Research Institute, Department of Orthopedics, Sichuan University West China Hospital, Chengdu, Sichuan, China.
Li M; Orthopedic Research Institute, Department of Orthopedics, Sichuan University West China Hospital, Chengdu, Sichuan, China.
Wu L; Orthopedic Research Institute, Department of Orthopedics, Sichuan University West China Hospital, Chengdu, Sichuan, China.
Shen B; Orthopedic Research Institute, Department of Orthopedics, Sichuan University West China Hospital, Chengdu, Sichuan, China.
Pokaż więcej
Źródło:
Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2022 Dec 09; Vol. 13, pp. 996244. Date of Electronic Publication: 2022 Dec 09 (Print Publication: 2022).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Fractures, Spontaneous*/genetics
Fractures, Spontaneous*/metabolism
Iron*/adverse effects
Iron*/metabolism
Osteoporosis*/genetics
Osteoporosis*/metabolism
Humans ; Ferritins ; Genome-Wide Association Study ; Mendelian Randomization Analysis ; Transferrins ; Female ; Osteoporosis, Postmenopausal/genetics ; Osteoporosis, Postmenopausal/metabolism
Czasopismo naukowe
Tytuł:
Low BMI, blood calcium and vitamin D, kyphosis time, and outdoor activity time are independent risk factors for osteoporosis in postmenopausal women.
Autorzy:
Tang G; Department of Pain, The First Medical Center of People's Liberation Army (PLA) General Hospital, Beijing, China.
Feng L; Department of Pain, The First Medical Center of People's Liberation Army (PLA) General Hospital, Beijing, China.; Department of Anesthesiology, People's Liberation Army (PLA) General Hospital of Hainan Hospital, Sanya, Hainan, China.
Pei Y; Department of Endocrinology, The First Medical Center of People's Liberation Army (PLA) General Hospital, Beijing, China.
Gu Z; Department of Endocrinology, The Second Medical Center of People's Liberation Army (PLA) General Hospital, Beijing, China.
Chen T; Department of Anesthesia and Cardiopulmonary Bypass, Cardiovascular Medical Department, The Sixth Medical Center of Chinese People's Liberation Army General Hospital, Beijing, China.
Feng Z; Department of Pain, The First Medical Center of People's Liberation Army (PLA) General Hospital, Beijing, China.
Pokaż więcej
Źródło:
Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2023 Oct 23; Vol. 14, pp. 1154927. Date of Electronic Publication: 2023 Oct 23 (Print Publication: 2023).
Typ publikacji:
Journal Article
MeSH Terms:
Osteoporosis, Postmenopausal*/etiology
Osteoporosis, Postmenopausal*/complications
Osteoporosis*/etiology
Kyphosis*/complications
Humans ; Female ; Adult ; Middle Aged ; Aged ; Aged, 80 and over ; Vitamin D ; Calcium ; Body Mass Index ; Postmenopause ; Vitamins ; Risk Factors
Czasopismo naukowe
Tytuł:
Disturbed bone marrow adiposity in patients with Cushing's syndrome and glucocorticoid- and postmenopausal- induced osteoporosis.
Autorzy:
Sørensen NN; Research Unit of Pathology, Department of Clinical Research, University of Southern Denmark, Odense, Denmark.; Department of Pathology, Odense University Hospital, Odense, Denmark.; Department of Molecular Medicine, University of Southern Denmark, Odense, Denmark.
Andreasen CM; Research Unit of Pathology, Department of Clinical Research, University of Southern Denmark, Odense, Denmark.; Department of Pathology, Odense University Hospital, Odense, Denmark.; Department of Molecular Medicine, University of Southern Denmark, Odense, Denmark.; Danish Spatial Imaging Consortium (DanSIC), Denmark.
Jensen PR; Clinical Cell Biology (KCB), Vejle/Lillebaelt Hospital, Institute of Regional Health Research (IRS), University of Southern Denmark, Vejle, Denmark.
Hauge EM; Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Bollerslev J; Section of Specialized Endocrinology, Oslo University Hospital, Oslo, Norway.; Faculty of Medicine, University of Oslo, Oslo, Norway.
Delaissé JM; Research Unit of Pathology, Department of Clinical Research, University of Southern Denmark, Odense, Denmark.; Department of Pathology, Odense University Hospital, Odense, Denmark.; Department of Molecular Medicine, University of Southern Denmark, Odense, Denmark.
Kassem M; Department of Cellular and Molecular Medicine, Novo Nordisk Foundation Center for Stem Cell Biology (DanStem), University of Copenhagen, Copenhagen, Denmark.; Molecular Endocrinology & Stem Cell Research Unit (KMEB), Department of Endocrinology and Metabolism, Odense University Hospital & University of Southern Denmark, Odense, Denmark.
Jafari A; Department of Cellular and Molecular Medicine, Novo Nordisk Foundation Center for Stem Cell Biology (DanStem), University of Copenhagen, Copenhagen, Denmark.; Molecular Endocrinology & Stem Cell Research Unit (KMEB), Department of Endocrinology and Metabolism, Odense University Hospital & University of Southern Denmark, Odense, Denmark.
Diaz-delCastillo M; Danish Spatial Imaging Consortium (DanSIC), Denmark.; Department of Forensic Medicine, Aarhus University, Aarhus, Denmark.
Andersen TL; Research Unit of Pathology, Department of Clinical Research, University of Southern Denmark, Odense, Denmark.; Department of Pathology, Odense University Hospital, Odense, Denmark.; Department of Molecular Medicine, University of Southern Denmark, Odense, Denmark.; Danish Spatial Imaging Consortium (DanSIC), Denmark.; Department of Forensic Medicine, Aarhus University, Aarhus, Denmark.
Pokaż więcej
Źródło:
Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2023 Oct 10; Vol. 14, pp. 1232574. Date of Electronic Publication: 2023 Oct 10 (Print Publication: 2023).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Cushing Syndrome*/complications
Cushing Syndrome*/pathology
Osteoporosis, Postmenopausal*
Osteoporosis*/pathology
Humans ; Female ; Bone Marrow/pathology ; Glucocorticoids/adverse effects ; Adiposity ; Postmenopause ; Hyperplasia/chemically induced ; Hydrocortisone/pharmacology ; Hypertrophy/chemically induced
Czasopismo naukowe
Tytuł:
Effect of bedside health education for elderly patients with fragility fracture by specialist physicians on the diagnosis and treatment of osteoporosis during hospitalization and the visiting rate to osteoporosis clinic after discharge in a high-volume orthopedic hospital.
Autorzy:
Yang J; Department of Osteoporosis, Honghui Hospital, Xi'an Jiaotong University, Xi'an, 710054, China.
Tang Q; Department of Osteoporosis, Honghui Hospital, Xi'an Jiaotong University, Xi'an, 710054, China.
Che M; Department of Osteoporosis, Honghui Hospital, Xi'an Jiaotong University, Xi'an, 710054, China.
Shi J; Department of Osteoporosis, Honghui Hospital, Xi'an Jiaotong University, Xi'an, 710054, China.
Yang L; Department of Osteoporosis, Honghui Hospital, Xi'an Jiaotong University, Xi'an, 710054, China.
Zeng Y; Department of Osteoporosis, Honghui Hospital, Xi'an Jiaotong University, Xi'an, 710054, China. .
Pokaż więcej
Źródło:
Archives of osteoporosis [Arch Osteoporos] 2023 Nov 13; Vol. 18 (1), pp. 133. Date of Electronic Publication: 2023 Nov 13.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Osteoporosis*/diagnosis
Osteoporosis*/epidemiology
Osteoporosis*/therapy
Osteoporotic Fractures*/diagnosis
Osteoporotic Fractures*/epidemiology
Osteoporotic Fractures*/therapy
Bone Density Conservation Agents*/therapeutic use
Physicians*
Humans ; Aged ; Retrospective Studies ; Patient Discharge ; Bone Density ; Hospitalization ; Health Education ; Hospitals
Czasopismo naukowe
Tytuł:
Long-term consequences of osteoporosis therapy with bisphosphonates.
Autorzy:
Gehrke B; Programa de Pós-graduação em Fisiopatologia Clínica e Experimental (FISCLINEX), Universidade Estadual do Rio de Janeiro, Rio de Janeiro, RJ, Brasil, barbara_.; Centro de Pesquisa Clínica Multiusuário (CePeM), Universidade Estadual do Rio de Janeiro, Rio de Janeiro, RJ, Brasil.; Divisão de Endocrinologia, Departamento de Medicina Interna, Faculdade de Ciências Médicas, Universidade Estadual do Rio de Janeiro, Rio de Janeiro, RJ, Brasil.
Alves Coelho MC; Programa de Pós-graduação em Fisiopatologia Clínica e Experimental (FISCLINEX), Universidade Estadual do Rio de Janeiro, Rio de Janeiro, RJ, Brasil.; Centro de Pesquisa Clínica Multiusuário (CePeM), Universidade Estadual do Rio de Janeiro, Rio de Janeiro, RJ, Brasil.; Divisão de Endocrinologia, Departamento de Medicina Interna, Faculdade de Ciências Médicas, Universidade Estadual do Rio de Janeiro, Rio de Janeiro, RJ, Brasil.
Brasil d'Alva C; Núcleo de Atendimento Multidisciplinar às Doenças Osteometabólicas, Departamento de Medicina Clínica, Universidade Federal do Ceará, Fortaleza, CE, Brasil.
Madeira M; Divisão de Endocrinologia, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brasil.
Pokaż więcej
Źródło:
Archives of endocrinology and metabolism [Arch Endocrinol Metab] 2023 Nov 10; Vol. 68, pp. e220334.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Bone Density Conservation Agents*/adverse effects
Osteoporosis*/drug therapy
Fractures, Bone*
Osteoporosis, Postmenopausal*/drug therapy
Humans ; Female ; Diphosphonates/adverse effects ; Quality of Life ; Alendronate ; Zoledronic Acid/therapeutic use
Czasopismo naukowe
Tytuł:
Elevated circulating levels of IL-34 are strongly associated with osteoporosis.
Autorzy:
Tarabeih N; Department of Morphological Studies, Adelson School of Medicine, Ariel University, 40700, Ariel, Israel.; Department of Nursing, The Max Stern Yezreel Valley College, 19300, Yezreel Valley, Israel.
Shalata A; Faculty of Medicine, The Simon Winter Institute for Human Genetics, Bnai Zion Medical Center, The Ruth and Bruce Rappaport, 32000, Technion, Haifa, Israel.
Kalinkovich A; Department of Anatomy and Anthropology, Sackler Faculty of Medicine, Tel-Aviv University, 6905126, Tel-Aviv, Israel.
Higla O; Orthopedics Clinic, Clalit, Migdal HaMeah, 6203854, Tel-Aviv, Israel.
Livshits G; Department of Morphological Studies, Adelson School of Medicine, Ariel University, 40700, Ariel, Israel. .; Department of Anatomy and Anthropology, Sackler Faculty of Medicine, Tel-Aviv University, 6905126, Tel-Aviv, Israel. .
Pokaż więcej
Źródło:
Archives of osteoporosis [Arch Osteoporos] 2023 Nov 10; Vol. 18 (1), pp. 132. Date of Electronic Publication: 2023 Nov 10.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Osteoporosis*
Osteoporosis, Postmenopausal*
Female ; Humans ; Bone Density ; Cross-Sectional Studies ; Interleukins ; Lumbar Vertebrae/metabolism
Czasopismo naukowe
Tytuł:
Age-dependent gender differences in the diagnosis and treatment of osteoporosis during hospitalization in patients with fragility fractures.
Autorzy:
Li Q; Department of Osteoporosis, Honghui Hospital, Xi'an Jiaotong University, No. 555 Youyi East Road, NanShaomen, Beilin District, Xi'an, 710054, China.
Yang J; Department of Osteoporosis, Honghui Hospital, Xi'an Jiaotong University, No. 555 Youyi East Road, NanShaomen, Beilin District, Xi'an, 710054, China.
Tang Q; Department of Osteoporosis, Honghui Hospital, Xi'an Jiaotong University, No. 555 Youyi East Road, NanShaomen, Beilin District, Xi'an, 710054, China.
Feng Y; Department of Osteoporosis, Honghui Hospital, Xi'an Jiaotong University, No. 555 Youyi East Road, NanShaomen, Beilin District, Xi'an, 710054, China.
Pan M; Department of Osteoporosis, Honghui Hospital, Xi'an Jiaotong University, No. 555 Youyi East Road, NanShaomen, Beilin District, Xi'an, 710054, China.
Che M; Department of Osteoporosis, Honghui Hospital, Xi'an Jiaotong University, No. 555 Youyi East Road, NanShaomen, Beilin District, Xi'an, 710054, China.
Shi J; Department of Osteoporosis, Honghui Hospital, Xi'an Jiaotong University, No. 555 Youyi East Road, NanShaomen, Beilin District, Xi'an, 710054, China.
Zeng Y; Department of Osteoporosis, Honghui Hospital, Xi'an Jiaotong University, No. 555 Youyi East Road, NanShaomen, Beilin District, Xi'an, 710054, China. .
Pokaż więcej
Źródło:
BMC geriatrics [BMC Geriatr] 2023 Nov 09; Vol. 23 (1), pp. 728. Date of Electronic Publication: 2023 Nov 09.
Typ publikacji:
Journal Article
MeSH Terms:
Osteoporosis*/diagnosis
Osteoporosis*/epidemiology
Osteoporosis*/therapy
Fractures, Bone*
Osteoporotic Fractures*/diagnosis
Osteoporotic Fractures*/epidemiology
Osteoporotic Fractures*/therapy
Humans ; Female ; Male ; Aged, 80 and over ; Sex Factors ; Bone Density ; Hospitalization
Czasopismo naukowe
Tytuł:
Recent advance of small-molecule drugs for clinical treatment of osteoporosis: A review.
Autorzy:
Zhang JY; College of Chemistry and Chemical Engineering, Zhengzhou Normal University, Zhengzhou, 450044, China.
Zhong YH; Department of Orthopedics, China-Japan Union Hospital, Jilin University, Changchun, 130033, China; Department of Orthopedics, The Fourth Affiliated Hospital of Guangxi Medical University/Liu-Zhou Worker's Hospital, Liuzhou, Guangxi, 545005, China.
Chen LM; Department of Orthopedics, The Fourth Affiliated Hospital of Guangxi Medical University/Liu-Zhou Worker's Hospital, Liuzhou, Guangxi, 545005, China.
Zhuo XL; Department of Orthopedics, The Fourth Affiliated Hospital of Guangxi Medical University/Liu-Zhou Worker's Hospital, Liuzhou, Guangxi, 545005, China.
Zhao LJ; The Rogel Cancer Center, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, 48109, United States. Electronic address: .
Wang YT; First People's Hospital of Shangqiu, Henan Province, Shangqiu, 476100, China; Department of Orthopedics, China-Japan Union Hospital, Jilin University, Changchun, 130033, China. Electronic address: .
Pokaż więcej
Źródło:
European journal of medicinal chemistry [Eur J Med Chem] 2023 Nov 05; Vol. 259, pp. 115654. Date of Electronic Publication: 2023 Jul 16.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Osteoporosis, Postmenopausal*/drug therapy
Osteoporosis*/drug therapy
Bone Density Conservation Agents*/pharmacology
Bone Density Conservation Agents*/therapeutic use
Female ; Humans ; Bone Density ; Diphosphonates/pharmacology ; Diphosphonates/therapeutic use ; Selective Estrogen Receptor Modulators/pharmacology
Czasopismo naukowe
Tytuł:
Comparison of anti-fracture effectiveness of zoledronate, ibandronate and alendronate versus denosumab in a registry-based cohort study.
Autorzy:
Everts-Graber J; OsteoRheuma Bern AG, Bahnhofplatz 1, CH- 3011, Bern, Switzerland. .; Department of Rheumatology and Immunology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland. .
Bonel H; Campus Stiftung Lindenhof Bern, Swiss Institute for Translational and Entrepreneurial Medicine, Bern, Switzerland.; Department of Radiology, Lindenhof Hospital, Bern, Switzerland.; Department of Radiology, Inselspital, University of Bern, Bern, Switzerland.
Lehmann D; Faculty of Medicine, University of Bern, Bern, Switzerland.
Gahl B; Clinical Trial Unit, University of Bern, Bern, Switzerland.
Häuselmann H; Zentrum Für Rheuma- Und Knochenerkrankungen, Klinik Im Park, Hirslanden Zurich, Switzerland.
Studer U; OsteoRheuma Bern AG, Bahnhofplatz 1, CH- 3011, Bern, Switzerland.
Ziswiler HR; OsteoRheuma Bern AG, Bahnhofplatz 1, CH- 3011, Bern, Switzerland.
Reichenbach S; Department of Rheumatology and Immunology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.; Institute for Social and Preventive Medicine, University of Bern, Bern, Switzerland.
Lehmann T; OsteoRheuma Bern AG, Bahnhofplatz 1, CH- 3011, Bern, Switzerland.
Pokaż więcej
Źródło:
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA [Osteoporos Int] 2023 Nov; Vol. 34 (11), pp. 1961-1973. Date of Electronic Publication: 2023 Jul 26.
Typ publikacji:
Journal Article
MeSH Terms:
Bone Density Conservation Agents*/adverse effects
Osteoporosis*/drug therapy
Hip Fractures*/complications
Spinal Fractures*/complications
Osteoporosis, Postmenopausal*/drug therapy
Humans ; Female ; Aged ; Middle Aged ; Male ; Alendronate/therapeutic use ; Ibandronic Acid/therapeutic use ; Zoledronic Acid/therapeutic use ; Denosumab/adverse effects ; Cohort Studies ; Diphosphonates/therapeutic use ; Registries
Czasopismo naukowe
Tytuł:
Secoisolariciresinol diglucoside regulates estrogen receptor expression to ameliorate OVX-induced osteoporosis.
Autorzy:
Chen G; Department of Orthopaedics, Zhejiang Xiaoshan Hospital, Hangzhou, 311200, Zhejiang Province, China. .
Chen Y; Department of Orthopaedics, Zhejiang Xiaoshan Hospital, Hangzhou, 311200, Zhejiang Province, China.
Hong J; Department of Orthopaedics, Zhejiang Xiaoshan Hospital, Hangzhou, 311200, Zhejiang Province, China.
Gao J; Department of Orthopaedics, Zhejiang Xiaoshan Hospital, Hangzhou, 311200, Zhejiang Province, China.
Xu Z; Department of Orthopaedics, Zhejiang Xiaoshan Hospital, Hangzhou, 311200, Zhejiang Province, China.
Pokaż więcej
Źródło:
Journal of orthopaedic surgery and research [J Orthop Surg Res] 2023 Oct 24; Vol. 18 (1), pp. 792. Date of Electronic Publication: 2023 Oct 24.
Typ publikacji:
Journal Article
MeSH Terms:
Osteoporosis*/drug therapy
Osteoporosis*/etiology
Osteoporosis*/metabolism
Osteoporosis, Postmenopausal*/drug therapy
Osteoporosis, Postmenopausal*/etiology
Female ; Humans ; Rats ; Animals ; Receptors, Estrogen ; Interleukin-6 ; Estrogens ; Bone Density ; Ovariectomy/adverse effects
Czasopismo naukowe
Tytuł:
Efficacy of switching from teriparatide to zoledronic acid or denosumab on bone mineral density and biochemical markers of bone turnover in older patients with severe osteoporosis: a real-life study.
Autorzy:
Dito G; Endocrinology and Diabetology Service, IRCCS Istituto Ortopedico Galeazzi, Milan, Italy.
Lugaresi M; Endocrinology and Diabetology Service, IRCCS Istituto Ortopedico Galeazzi, Milan, Italy.; Department of Biotechnology and Translational Medicine, University of Milan, Milan, Italy.
Degradi C; Endocrinology and Diabetology Service, IRCCS Istituto Ortopedico Galeazzi, Milan, Italy.; Department of Medical and Surgical Pathophysiology and Transplantation, University of Milan, Milan, Italy.
Guabello G; Endocrinology and Diabetology Service, IRCCS Istituto Ortopedico Galeazzi, Milan, Italy.
Longhi M; Rheumatology Unit, IRCCS Istituto Ortopedico Galeazzi, Milan, Italy.
Corbetta S; Bone Metabolism Diseases and Diabetes Unit, IRCCS Istituto Auxologico Italiano, Milan, Italy. .; Department of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, Italy. .
Pokaż więcej
Źródło:
Endocrine [Endocrine] 2023 Oct; Vol. 82 (1), pp. 181-189. Date of Electronic Publication: 2023 Jul 04.
Typ publikacji:
Journal Article
MeSH Terms:
Bone Density Conservation Agents*/adverse effects
Osteoporosis*/drug therapy
Osteoporosis*/chemically induced
Fractures, Bone*/chemically induced
Male ; Female ; Humans ; Aged ; Middle Aged ; Zoledronic Acid/therapeutic use ; Zoledronic Acid/pharmacology ; Teriparatide/adverse effects ; Bone Density ; Denosumab/adverse effects ; Retrospective Studies ; Diphosphonates/adverse effects ; Bone Remodeling ; Biomarkers
Czasopismo naukowe
Tytuł:
Efficacy and Safety of Transdermal Abaloparatide in Postmenopausal Women with Osteoporosis: A Randomized Study.
Autorzy:
Lewiecki EM; New Mexico Clinical Research & Osteoporosis Center, Albuquerque, NM, USA.
Czerwinski E; Krakow Medical Center, Krakow, Poland.
Recknor C; United Osteoporosis Centers, Gainesville, GA, USA.
Strzelecka A; SOMED, Łódź, Poland.
Valenzuela G; Integral Rheumatology & Immunology Specialist (IRIS), Plantation, FL, USA.
Lawrence M; Carteret Medical Group, Morehead City, NC, USA.
Silverman S; Osteoporosis Medical Center, Beverly Hills, CA, USA.
Cardona J; Indago Research & Health Center, Inc., Hialeah, FL, USA.
Nattrass SM; Puget Sound Osteoporosis Center, Burien, WA, USA.
Binkley N; University of Wisconsin Osteoporosis Clinical Research Program, Madison, WI, USA.
Annett M; Radius Health, Inc., Boston, MA, USA.
Pearman L; Radius Health, Inc., Boston, MA, USA.
Mitlak B; Radius Health, Inc., Boston, MA, USA.
Pokaż więcej
Źródło:
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research [J Bone Miner Res] 2023 Oct; Vol. 38 (10), pp. 1404-1414. Date of Electronic Publication: 2023 Jul 27.
Typ publikacji:
Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Osteoporosis, Postmenopausal*/drug therapy
Osteoporosis, Postmenopausal*/complications
Bone Density Conservation Agents*/adverse effects
Osteoporosis*/drug therapy
Osteoporotic Fractures*/drug therapy
Humans ; Female ; Postmenopause ; Bone Density ; Lumbar Vertebrae ; Minerals
Czasopismo naukowe
Tytuł:
Drug utilization analysis of osteoporosis medications in seven European electronic health databases.
Autorzy:
Tan EH; Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, OX3 7LD, UK.
Robinson DE; Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, OX3 7LD, UK.
Jödicke AM; Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, OX3 7LD, UK.
Mosseveld M; Department of Medical Informatics, Erasmus University Medical Centre, Rotterdam, The Netherlands.
Bødkergaard K; Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark.
Reyes C; Fundació Institut Universitari Per a La Recerca a L'Atenció Primària de Salut Jordi Gol I Gurina (IDIAPJGol), Barcelona, Spain.
Moayyeri A; UCB Pharma, Slough, UK.
Voss A; Department of Clinical Epidemiology, Leibniz Institute for Prevention Research and Epidemiology - BIPS, Bremen, Germany.
Marconi E; Health Search, Italian College of General Practitioners and Primary Care, Florence, Italy.
Lapi F; Health Search, Italian College of General Practitioners and Primary Care, Florence, Italy.
Reinold J; Department of Clinical Epidemiology, Leibniz Institute for Prevention Research and Epidemiology - BIPS, Bremen, Germany.
Verhamme KMC; Department of Medical Informatics, Erasmus University Medical Centre, Rotterdam, The Netherlands.
Pedersen L; Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark.
Braitmaier M; Department of Biometry and Data Management, Leibniz Institute for Prevention Research and Epidemiology - BIPS, Bremen, Germany.
de Wilde M; Department of Medical Informatics, Erasmus University Medical Centre, Rotterdam, The Netherlands.
Ruiz MF; Fundació Institut Universitari Per a La Recerca a L'Atenció Primària de Salut Jordi Gol I Gurina (IDIAPJGol), Barcelona, Spain.
Aragón M; Fundació Institut Universitari Per a La Recerca a L'Atenció Primària de Salut Jordi Gol I Gurina (IDIAPJGol), Barcelona, Spain.
Bosco-Levy P; Univ. Bordeaux, INSERM CIC-P1401, Bordeaux PharmacoEpi, Bordeaux, France.
Lassalle R; Univ. Bordeaux, INSERM CIC-P1401, Bordeaux PharmacoEpi, Bordeaux, France.
Prieto-Alhambra D; Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, OX3 7LD, UK. .; Department of Medical Informatics, Erasmus University Medical Centre, Rotterdam, The Netherlands. .
Sanchez-Santos MT; Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, OX3 7LD, UK.
Pokaż więcej
Źródło:
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA [Osteoporos Int] 2023 Oct; Vol. 34 (10), pp. 1771-1781. Date of Electronic Publication: 2023 Jul 12.
Typ publikacji:
Journal Article
MeSH Terms:
Bone Density Conservation Agents*/therapeutic use
Osteoporosis*/drug therapy
Osteoporosis, Postmenopausal*/drug therapy
Adult ; Humans ; Female ; Male ; Alendronate/therapeutic use ; Teriparatide/therapeutic use ; Denosumab/therapeutic use ; Cohort Studies ; Selective Estrogen Receptor Modulators ; Diphosphonates/therapeutic use ; Drug Utilization ; Electronics
Czasopismo naukowe
Tytuł:
The beneficial effects of simultaneous supplementation of Lactobacillus reuteri and calcium fluoride nanoparticles on ovariectomy-induced osteoporosis.
Autorzy:
Rahmani D; Department of Biology, Central Tehran Branch, Islamic Azad University, Tehran, Iran.
Faal B; Department of Biology, Central Tehran Branch, Islamic Azad University, Tehran, Iran.
Zali H; Department of Tissue Engineering and Applied Cell Sciences, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Tackallou SH; Department of Biology, Central Tehran Branch, Islamic Azad University, Tehran, Iran. .
Niknam Z; Neurophysiology Research Center, Cellular and Molecular Medicine research Institute, Urmia University of Medical Sciences, Urmia, Iran. .
Pokaż więcej
Źródło:
BMC complementary medicine and therapies [BMC Complement Med Ther] 2023 Sep 26; Vol. 23 (1), pp. 340. Date of Electronic Publication: 2023 Sep 26.
Typ publikacji:
Journal Article
MeSH Terms:
Limosilactobacillus reuteri*
Osteoporosis*/drug therapy
Osteoporosis, Postmenopausal*
Female ; Animals ; Rats ; Humans ; Rats, Wistar ; Calcium Fluoride ; Alkaline Phosphatase ; Calcium ; Estrogens ; Dietary Supplements
Czasopismo naukowe
Tytuł:
Association of inflammatory markers with all-cause mortality and cardiovascular mortality in postmenopausal women with osteoporosis or osteopenia.
Autorzy:
Qu L; Department of Laboratory, Taian Maternity And Child Health Hospital, No.386 Longtan Road, Gaoxin District, Tai'an, 271000, People's Republic of China.
Zuo X; Department of Blood Transfusion, Taian Maternity And Child Health Hospital, Tai'an, 271000, People's Republic of China.
Yu J; Department of Newborn Disease Screening, Taian Maternity And Child Health Hospital, Tai'an, 271000, People's Republic of China.
Duan R; Department of Laboratory, Taian Maternity And Child Health Hospital, No.386 Longtan Road, Gaoxin District, Tai'an, 271000, People's Republic of China.
Zhao B; Department of Laboratory, Taian Maternity And Child Health Hospital, No.386 Longtan Road, Gaoxin District, Tai'an, 271000, People's Republic of China. .
Pokaż więcej
Źródło:
BMC women's health [BMC Womens Health] 2023 Sep 14; Vol. 23 (1), pp. 487. Date of Electronic Publication: 2023 Sep 14.
Typ publikacji:
Journal Article
MeSH Terms:
Osteoporosis*
Bone Diseases, Metabolic*
Osteoporosis, Postmenopausal*
Cardiovascular Diseases*
Female ; Humans ; Nutrition Surveys ; Postmenopause ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Four-year treatment continuation rates of osteoporosis drugs with different dosing intervals  throughout Japan.
Autorzy:
Idei K; Department of Orthopaedic Surgery, Kanai Hospital, Kyoto, Japan.; Department of Orthopaedics, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Ryu K; Department of Orthopaedic Surgery, Kanai Hospital, Kyoto, Japan.
Miura S; Department of Orthopaedic Surgery, Kanai Hospital, Kyoto, Japan.
Hiraga K; The Real World Data Co., Ltd, Kyoto, Japan.
Hayama Y; The Real World Data Co., Ltd, Kyoto, Japan.
Suzuki A; Nara Prefectural University, Nara, Japan.
Okubo N; Department of Orthopaedics, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Arai Y; Department of Sports and Para-Sports Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Takahashi K; Department of Orthopaedics, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Pokaż więcej
Źródło:
Geriatrics & gerontology international [Geriatr Gerontol Int] 2023 Sep; Vol. 23 (9), pp. 665-670. Date of Electronic Publication: 2023 Jul 16.
Typ publikacji:
Journal Article
MeSH Terms:
Osteoporosis*/drug therapy
Bone Density Conservation Agents*/therapeutic use
Osteoporosis, Postmenopausal*/drug therapy
Humans ; Female ; Diphosphonates/therapeutic use ; Japan/epidemiology
Czasopismo naukowe
Tytuł:
Myrislignan targets extracellular signal-regulated kinase (ERK) and modulates mitochondrial function to dampen osteoclastogenesis and ovariectomy-induced osteoporosis.
Autorzy:
Yang T; Guangxi Key Laboratory of Regenerative Medicine, Orthopaedic Department, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi, China.; Collaborative Innovation Centre of Regenerative Medicine and Medical BioResource Development and Application Co-constructed by the Province and Ministry, Life Sciences Institute, Guangxi Medical University, Nanning, 530021, Guangxi, China.
Chen W; Guangxi Key Laboratory of Regenerative Medicine, Orthopaedic Department, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi, China.; Collaborative Innovation Centre of Regenerative Medicine and Medical BioResource Development and Application Co-constructed by the Province and Ministry, Life Sciences Institute, Guangxi Medical University, Nanning, 530021, Guangxi, China.
Gan K; Guangxi Key Laboratory of Regenerative Medicine, Orthopaedic Department, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi, China.
Wang C; Guangxi Key Laboratory of Regenerative Medicine, Orthopaedic Department, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi, China.; Collaborative Innovation Centre of Regenerative Medicine and Medical BioResource Development and Application Co-constructed by the Province and Ministry, Life Sciences Institute, Guangxi Medical University, Nanning, 530021, Guangxi, China.
Xie X; Guangxi Key Laboratory of Regenerative Medicine, Orthopaedic Department, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi, China.; Collaborative Innovation Centre of Regenerative Medicine and Medical BioResource Development and Application Co-constructed by the Province and Ministry, Life Sciences Institute, Guangxi Medical University, Nanning, 530021, Guangxi, China.
Su Y; Guangxi Key Laboratory of Regenerative Medicine, Orthopaedic Department, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi, China.; Collaborative Innovation Centre of Regenerative Medicine and Medical BioResource Development and Application Co-constructed by the Province and Ministry, Life Sciences Institute, Guangxi Medical University, Nanning, 530021, Guangxi, China.
Lian H; Guangxi Key Laboratory of Regenerative Medicine, Orthopaedic Department, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi, China.; Collaborative Innovation Centre of Regenerative Medicine and Medical BioResource Development and Application Co-constructed by the Province and Ministry, Life Sciences Institute, Guangxi Medical University, Nanning, 530021, Guangxi, China.
Xu J; School of Biomedical Sciences, the University of Western Australia, Perth, WA, 6009, Australia. .
Zhao J; Guangxi Key Laboratory of Regenerative Medicine, Orthopaedic Department, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi, China. .
Liu Q; Guangxi Key Laboratory of Regenerative Medicine, Orthopaedic Department, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, Guangxi, China. .; Collaborative Innovation Centre of Regenerative Medicine and Medical BioResource Development and Application Co-constructed by the Province and Ministry, Life Sciences Institute, Guangxi Medical University, Nanning, 530021, Guangxi, China. .
Pokaż więcej
Źródło:
Journal of translational medicine [J Transl Med] 2023 Nov 22; Vol. 21 (1), pp. 839. Date of Electronic Publication: 2023 Nov 22.
Typ publikacji:
Journal Article
MeSH Terms:
Bone Resorption*/pathology
Osteoporosis*/drug therapy
Osteoporosis*/etiology
Osteoporosis*/metabolism
Humans ; Female ; Mice ; Animals ; Osteogenesis ; Extracellular Signal-Regulated MAP Kinases/metabolism ; Osteoclasts ; NF-kappa B/metabolism ; Cell Differentiation ; Ovariectomy ; RANK Ligand/metabolism
Czasopismo naukowe
Tytuł:
Anti-NF-κB peptide derived from nuclear acidic protein attenuates ovariectomy-induced osteoporosis in mice.
Autorzy:
Takami K; Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.; Department of Orthopaedic Surgery, Nippon Life Hospital, Nishi-ku, Osaka, Japan.
Okamoto K; Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Etani Y; Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Hirao M; Department of Orthopaedic Surgery, National Hospital Organization Osaka Minami Medical Center, Kawachinagano, Osaka, Japan.
Miyama A; Department of Orthopaedic Surgery, National Hospital Organization Osaka Toneyama Medical Center, Toyonaka, Osaka, Japan.
Okamura G; Department of Orthopaedic Surgery, Osaka Rosai Hospital, Kita-ku, Sakai, Japan.
Goshima A; Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Miura T; Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Kurihara T; Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Fukuda Y; Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Kanamoto T; Department of Health and Sport Sciences, and.
Nakata K; Department of Health and Sport Sciences, and.
Okada S; Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Ebina K; Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.; Department of Musculoskeletal Regenerative Medicine, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Pokaż więcej
Źródło:
JCI insight [JCI Insight] 2023 Nov 22; Vol. 8 (22). Date of Electronic Publication: 2023 Nov 22.
Typ publikacji:
Journal Article
MeSH Terms:
NF-kappa B*/metabolism
Osteoporosis*/drug therapy
Osteoporosis*/etiology
Osteoporosis*/prevention & control
Female ; Mice ; Animals ; Humans ; Osteoclasts/metabolism ; Nuclear Proteins ; Peptides/pharmacology ; Peptides/therapeutic use ; Ovariectomy/adverse effects
Czasopismo naukowe
Tytuł:
Inokosterone activates the BMP2 to promote the osteogenic differentiation of bone marrow mesenchymal stem cells and improve bone loss in ovariectomized rats.
Autorzy:
Chen Q; Department of Orthopedics, Affiliated Xiaoshan Hospital, Hangzhou Normal University, Hangzhou, 311200, China.
Yang Z; Department of Orthopedics, Affiliated Xiaoshan Hospital, Hangzhou Normal University, Hangzhou, 311200, China.
Sun X; Department of Orthopedics, Affiliated Xiaoshan Hospital, Hangzhou Normal University, Hangzhou, 311200, China.
Long R; Department of Orthopedics, Affiliated Xiaoshan Hospital, Hangzhou Normal University, Hangzhou, 311200, China.
Shen J; Department of Orthopedics, Affiliated Xiaoshan Hospital, Hangzhou Normal University, Hangzhou, 311200, China.
Wang Z; Department of Orthopedics, Affiliated Xiaoshan Hospital, Hangzhou Normal University, Hangzhou, 311200, China. Electronic address: .
Pokaż więcej
Źródło:
Biochemical and biophysical research communications [Biochem Biophys Res Commun] 2023 Nov 19; Vol. 682, pp. 349-358. Date of Electronic Publication: 2023 Oct 09.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Osteoporosis*/therapy
Osteoporosis*/metabolism
Mesenchymal Stem Cells*
Calcinosis*/metabolism
Female ; Rats ; Mice ; Animals ; Osteogenesis ; Core Binding Factor Alpha 1 Subunit/genetics ; Core Binding Factor Alpha 1 Subunit/metabolism ; Cell Differentiation ; Bone Morphogenetic Proteins/metabolism ; Bone Marrow Cells ; Cells, Cultured ; Antigens, Differentiation/metabolism
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies